USA Institutional Investor Activity — July 31, 2026

Holds 324,998 shares of Apple and 88,567 shares of Amazon, indicating strong conviction in mega-cap tech, but pairs these with listed call and put options, suggesting a hedged or tactical overlay rather than a pure long bet [BULLISH/BEARISH MIXED]

Largest single position is Zevia PBC (699,189 shares), a small-cap consumer stock, which may indicate a deep-value or turnaround play, but the lack of market values makes risk assessment impossible

Holds 338,885 shares of Oscar Health (OSCR), a volatile health insurance name, representing a significant concentration that could signal insider conviction or a bet on regulatory tailwinds

Large position in GraniteShares 2x NVDA ETF (190,401 shares) shows a leveraged bet on Nvidia, reflecting bullish sentiment on AI/semiconductors, but the options hedging may cap upside

Heavy allocation to fixed-income ETFs (iShares iBoxx Inv Cp: 99,972 shares, PGIM Ultra Sh Bd: 185,341 shares) suggests a defensive, income-focused strategy, likely anticipating stable or falling rates

Includes positions in Exxon Mobil (71,190 shares) and Chevron, indicating energy sector exposure, which may hedge against inflation or geopolitical risks

Holds 297,500 shares of Ericsson (ERIC) ADR, a telecom equipment play, which could be a contrarian bet on 5G/network infrastructure spending

Mixed sentiment (bullish on core tech, bearish via puts) suggests the manager expects near-term volatility but long-term growth, a common positioning ahead of earnings season

The extensive use of call and put options without clear delta exposure creates opacity; a sharp market move could trigger margin calls or unexpected losses

Single-stock position in Zevia PBC (699,189 shares) with no market value disclosed—if this is a large % of AUM, a 50% drawdown in the stock would materially impact the portfolio

Health insurance stocks are highly sensitive to regulatory changes (e.g., ACA subsidies, Medicare Advantage rates); any negative policy shift could crush the 338,885-share position

The 2x NVDA ETF amplifies both gains and losses; a 20% drop in Nvidia would result in a ~40% loss on that position, magnifying downside

Neither filing includes period-over-period comparisons, forward guidance, or insider trading activity, making it impossible to detect deteriorating trends or management sentiment

Large holdings in bond ETFs (iShares iBoxx, PGIM Ultra Short) could face price declines if the Fed surprises with rate hikes, though ultra-short duration mitigates this

Exxon and Chevron positions are vulnerable to oil price declines amid global recession fears or OPEC+ supply increases

The 338,885-share position could be a pre-earnings bet; Oscar Health reports Q2 results in August 2026—if medical cost ratios improve, the stock could rally significantly

The 2x NVDA ETF position (190,401 shares) is a high-conviction bet on AI; if Nvidia beats earnings (expected late August), this position could deliver outsized returns

The 134,954-share position in Nuveen Muni High Income offers tax-free yield; with muni supply tight, this could provide stable income in a flat market

The large Apple position (324,998 shares) combined with options suggests a collar strategy; if Apple's services revenue accelerates, the upside could be substantial

The 297,500-share position in Ericsson may be a contrarian bet on 5G spending recovery; if the company reports improved margins in Q3, the stock could re-rate

The 88,567-share Amazon position is a bet on AWS growth and retail margin expansion; with AWS re:Invent in November, cloud demand could be a catalyst

The 110,072-share position in PPL Corp offers regulated utility exposure; with rate cases pending in Kentucky and Pennsylvania, earnings could beat estimates

ZEGA's active options overlay contrasts with BCS's buy-and-hold fixed-income approach, reflecting divergent views on near-term volatility—one manager is hedging, the other is collecting yield

Both filings show significant exposure to large-cap tech (Apple, Amazon, Nvidia via ZEGA), suggesting institutional comfort with high-valuation names despite macro uncertainty

BCS's outsized Oscar Health position (338,885 shares) and ZEGA's potential healthcare options (not detailed) indicate selective risk-taking in the healthcare sector, possibly ahead of election-year policy clarity

BCS's heavy allocation to bond ETFs (iShares iBoxx, PGIM Ultra Short, Nuveen Muni) underscores continued institutional demand for income and capital preservation, even with rate uncertainty

ZEGA's Exxon and Chevron holdings suggest energy is being used as an inflation hedge or geopolitical risk offset, a common theme among institutional portfolios in 2026

Due by November 14, 2026—watch for changes in option positions (puts vs. calls) to gauge directional shift in market outlook

Expected in August 2026—the 338,885-share position makes this a key catalyst; watch for medical cost ratio and membership growth

Late August 2026—the 2x NVDA ETF position is highly sensitive to Nvidia's AI chip demand guidance

Watch for any insider buying or selling at Zevia; the 699,189-share position is a red flag for concentration unless the manager has deep conviction

Fed meeting September 2026—BCS's bond ETFs and ZEGA's options are rate-sensitive; a hawkish surprise could pressure both portfolios

September 2026 iPhone event—the 324,998-share position could benefit from strong upgrade cycle if AI features drive demand

October 2026—the 297,500-share position hinges on 5G equipment demand recovery in North America and Europe